title: Does a glutamate receptor blocker (Caroverine) enhance haloperidol in the treatment of schizophrenia?
authors.affiliation: Landeskrankenhaus Rankweil, Rankweil, Austria.
authors.forename: P
authors.initials: P
authors.lastname: König
authors.forename: A
authors.initials: A
authors.lastname: Conca
authors.forename: B
authors.initials: B
authors.lastname: Lugmayer
mesh_terms: D000328:Adult; D014150:Antipsychotic Agents / Q000627:therapeutic use*; D004357:Drug Synergism; D018691:Excitatory Amino Acid Antagonists / Q000627:therapeutic use*; D005260:Female; D006220:Haloperidol / Q000627:therapeutic use*; D006801:Humans; D008297:Male; D008875:Middle Aged; D010865:Pilot Projects; D011569:Psychiatric Status Rating Scales; D011810:Quinoxalines / Q000627:therapeutic use*; D012189:Retrospective Studies; D012559:Schizophrenia / Q000188:drug therapy*; D012565:Schizophrenic Psychology
chemical_list: D014150:Antipsychotic Agents; D018691:Excitatory Amino Acid Antagonists; D011810:Quinoxalines; D006220:Haloperidol; C000957:caroverine